-
2024-518210-81-00
5
2026-03-18
Advanced Hepatocellular Carcinoma
-
2025-521762-99-00
5
2026-03-09
acute ischemic stroke
-
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2024-515765-34-00
5
2026-02-04
English
First-line extensive-stage small-cell lung cancer (ES-SCLC)
-
2023-507879-21-00
4
2026-01-19
AML and MDS undergoing allogeneic Transplantation
-
2022-500676-59-00
4
2025-12-18
EBV-positive nasopharyngeal carcinoma
-
2025-520825-19-00
5
2025-12-16
IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as
Ber
-
2025-521738-27-00
4
2025-12-15
Recurrent Metastatic Head and Neck Cancer
-
2024-518465-10-00
4
2025-12-12
Multiple Autoimmune Glomerular Diseases
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2025-520896-13-00
5
2025-12-04
Friedreich’s ataxia
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2024-520219-42-00
10
2025-11-18
ivosidenib maintenance after SOC adjuvant chemotherapy in curative mID
-
2024-518008-33-00
5
2025-11-12
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
-
2024-519654-37-00
10
2025-11-07
Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
-
2024-517877-26-00
10
2025-10-16
Pancreatic resection
-
2024-517330-18-00
4
2025-10-02
advanced, non resectable or metastatic cholangio- or gallbladder carci
-
2023-509861-19-01
4
2025-09-30
High-grade B-cell lymphoma (HGBL)
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2025-521051-23-00
4
2025-08-06
metastatic castration-resistant prostate cancer
-
2024-517529-26-00
5
2025-08-04
Chronic Inflammatory Demyelinating Polyneuropathy
-
2023-507790-18-00
4
2025-08-01
cirrhosis and ascites
-
2023-509055-14-00
4
2025-06-17
myelodysplastic neoplasia (MDS)